Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease

Objectives: Readmission rate is increasingly being viewed as a key indicator of health system performance. Medication regimen complexity index scores may be predictive of readmissions; however, few studies have examined this potential association. The primary objective of this study was to determine...

Full description

Bibliographic Details
Main Authors: Nada Abou-Karam, Chad Bradford, Kajua B Lor, Mitchell Barnett, Michelle Ha, Albert Rizos
Format: Article
Language:English
Published: SAGE Publishing 2016-02-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312116632426
id doaj-78a7e13e6a9f4e2f83d1ecf2ff5aa84f
record_format Article
spelling doaj-78a7e13e6a9f4e2f83d1ecf2ff5aa84f2020-11-25T03:17:52ZengSAGE PublishingSAGE Open Medicine2050-31212016-02-01410.1177/205031211663242610.1177_2050312116632426Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary diseaseNada Abou-Karam0Chad Bradford1Kajua B Lor2Mitchell Barnett3Michelle Ha4Albert Rizos5Department of Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USADepartment of Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USADepartment of Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USADepartment of Clinical Sciences, Touro University California College of Pharmacy, Vallejo, CA, USACollege of Pharmacy, Western University of Health Sciences, Pomona, CA, USASystem Pharmacy Services, Sharp Healthcare, San Diego, CA, USAObjectives: Readmission rate is increasingly being viewed as a key indicator of health system performance. Medication regimen complexity index scores may be predictive of readmissions; however, few studies have examined this potential association. The primary objective of this study was to determine whether medication regimen complexity index is associated with all-cause 30-day readmission after admission for heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease. Methods: This study was an institutional review board–approved, multi-center, case–control study. Patients admitted with a primary diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease were randomly selected for inclusion. Patients were excluded if they discharged against medical advice or expired during their index visit. Block randomization was utilized for equal representation of index diagnosis and site. Discharge medication regimen complexity index scores were compared between subjects with readmission versus those without. Medication regimen complexity index score was then used as a predictor in logistic regression modeling for readmission. Results: Seven hundred and fifty-six patients were randomly selected for inclusion, and 101 (13.4%) readmitted within 30 days. The readmission group had higher medication regimen complexity index scores than the no-readmission group ( p  < 0.01). However, after controlling for demographics, disease state, length of stay, site, and medication count, medication regimen complexity index was no longer a significant predictor of readmission (odds ratio 0.99, 95% confidence interval 0.97–1.01) or revisit (odds ratio 0.99, 95% confidence interval 0.98–1.02). Conclusion: There is little evidence to support the use of medication regimen complexity index in readmission prediction when other measures are available. Medication regimen complexity index may lack sufficient sensitivity to capture an effect of medication regimen complexity on all-cause readmission.https://doi.org/10.1177/2050312116632426
collection DOAJ
language English
format Article
sources DOAJ
author Nada Abou-Karam
Chad Bradford
Kajua B Lor
Mitchell Barnett
Michelle Ha
Albert Rizos
spellingShingle Nada Abou-Karam
Chad Bradford
Kajua B Lor
Mitchell Barnett
Michelle Ha
Albert Rizos
Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
SAGE Open Medicine
author_facet Nada Abou-Karam
Chad Bradford
Kajua B Lor
Mitchell Barnett
Michelle Ha
Albert Rizos
author_sort Nada Abou-Karam
title Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
title_short Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
title_full Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
title_fullStr Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
title_full_unstemmed Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
title_sort medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease
publisher SAGE Publishing
series SAGE Open Medicine
issn 2050-3121
publishDate 2016-02-01
description Objectives: Readmission rate is increasingly being viewed as a key indicator of health system performance. Medication regimen complexity index scores may be predictive of readmissions; however, few studies have examined this potential association. The primary objective of this study was to determine whether medication regimen complexity index is associated with all-cause 30-day readmission after admission for heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease. Methods: This study was an institutional review board–approved, multi-center, case–control study. Patients admitted with a primary diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease were randomly selected for inclusion. Patients were excluded if they discharged against medical advice or expired during their index visit. Block randomization was utilized for equal representation of index diagnosis and site. Discharge medication regimen complexity index scores were compared between subjects with readmission versus those without. Medication regimen complexity index score was then used as a predictor in logistic regression modeling for readmission. Results: Seven hundred and fifty-six patients were randomly selected for inclusion, and 101 (13.4%) readmitted within 30 days. The readmission group had higher medication regimen complexity index scores than the no-readmission group ( p  < 0.01). However, after controlling for demographics, disease state, length of stay, site, and medication count, medication regimen complexity index was no longer a significant predictor of readmission (odds ratio 0.99, 95% confidence interval 0.97–1.01) or revisit (odds ratio 0.99, 95% confidence interval 0.98–1.02). Conclusion: There is little evidence to support the use of medication regimen complexity index in readmission prediction when other measures are available. Medication regimen complexity index may lack sufficient sensitivity to capture an effect of medication regimen complexity on all-cause readmission.
url https://doi.org/10.1177/2050312116632426
work_keys_str_mv AT nadaaboukaram medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
AT chadbradford medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
AT kajuablor medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
AT mitchellbarnett medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
AT michelleha medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
AT albertrizos medicationregimencomplexityandreadmissionsafterhospitalizationforheartfailureacutemyocardialinfarctionpneumoniaandchronicobstructivepulmonarydisease
_version_ 1724629448665333760